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Abstract: Resonance Raman spectroscopy is used to document, for the first 
time, a 6 cm−1 decrease of the Fe-S stretch by introducing an H-bond donor 
into the proximal pocket of a cytochrome P450, which interacts with the key 
cysteine thiolate axial ligand. The anticipated trans-effect on bound 
exogenous ligands is also confirmed and evidence is obtained supporting 
intimate interaction of the new histidyl-imidazole fragment with the heme 
periphery. 
Keywords: biophysics, heme proteins, oxidoreductases, Raman spectroscopy 
Members of the widely distributed cytochrome P450 class of 
monoxygenases, or CYPs, generate highly reactive oxygen-derived 
intermediates that effect a diverse set of reactions, including 
hydroxylation and epoxidation of relatively inert substrates,[1–3] 
thereby facilitating such important physiological functions as steroid 
biosynthesis and metabolism of pharmaceuticals.[4,5] The active site 
heme b is bound by a proximal cysteine thiolate, while on the distal 
side the heme is presented with an intricately arranged set of residues 
facilitating proton transfer to ferric peroxo- and ferric hydroperoxo-
species.[6] Substrate binding to the six coordinate, low-spin (6cLS) 
ferric resting state converts it to a five-coordinate, high-spin state 
(5cHS) that is reduced by natural redox partners, with the resulting 
ferrous form then binding dioxygen. Normally, the enzymatic cycle 
continues on to completion (oxidation of substrate) by accepting one 
more electron from a reductase to generate a peroxo-intermediate. 
Sequential delivery of two protons generates an initial hydroperoxo-
intermediate and then the so-called Compound I, a potent oxidizing 
species generally formulated as a ferryl heme π-cation radical.[1–3,7] 
Understandably, there is considerable interest in gaining insight into 
the structural factors that control the reactivity of the intermediates 
encountered within this cycle.[8–10] One obvious point of interest is that 
the strongly electron donating axial thiolate of all CYPs and structurally 
related enzymes, such as Nitric Oxide Synthases (NOSs), can promote 
O-O bond cleavage or impact the behavior of subsequent 
intermediates.[11–15] The effective negative charge on this proximal 
cysteine-thiolate could be fine-tuned by the nature and number of 
suitably positioned H-bond donors known to be present in the proximal 
pocket[14–23] A direct measure of the immediate consequences of such 
H-bonding is documentation of the strength of the Fe-S linkage, a task 
most readily accomplished by resonance Raman (rR) spectroscopy, 
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using excitation within the S→ Fe charge transfer transition envelope 
that occurs near 360 nm in the ferric HS form.[14,16–18,24–26] In the 
present work this direct spectroscopic method is used to interrogate 
active site structural changes that accompany a single site mutation of 
a truncated form of CYP2B4; i.e., the F429H variant, where the highly 
conserved proximal-side phenylalanine is replaced with the potentially 
H-bonding histidyl residue. The essential results obtained provide new 
definitive experimental evidence for the influence of proximal-side H-
bonding on the key Fe-S linkage and its effects on the cytochrome 
P450 cycle. 
This F429H mutant is of great interest, because the presence of 
this additional H-bond drastically diminished the enzyme’s ability to 
promote O-O bond cleavage.[9] Additionally, computational studies 
have suggested that the mutant’s heme oxygenase activity could arise 
as a result of a predicted weakening of the Fe-S bond strength.[15] 
Figure 1 shows the Soret band-excited rR spectra obtained for the 
substrate-free (SF) and butylated hydroxytoluene (BHT)-bound “wild 
type” ferric CYP2B4 and its F429H mutant. In the case of the WT 
enzyme (traces A and B), substrate binding causes an almost complete 
conversion from a 6cLS to 5cHS state; i.e. the ν3 “spin-state marker” 
shifts from 1502 to 1487 cm−1.[27–29] 
 
Figure 1 The low (left) and high (right) frequency rR spectra of ferric CYP2B4, 
wild-type substrate-free (A), wild-type BHT-bound (B), F429H mutant substrate-free 
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(C) and F429H mutant BHT-bound. Spectra measured with 406 nm excitation line and 
normalized to the ν3 mode. 
Similar behavior is documented for the F429H mutant, though 
the conversion is not as complete. This residual 6cLS fraction seen for 
the mutant might arise from decreased affinity for the substrate or 
from a conformational heterogeneity that increases the stability of the 
aquo-bound form. However, the absence of the SF form for the CO 
adduct (vide infra) argues against the former case, unless one invokes 
a significantly different substrate affinity between the ferric and 
ferrous forms. In the low frequency region the bending modes 
associated with the propionate and vinyl substituents are observed 
near ~370 cm−1 and 400–440 cm−1, respectively. In contrast to 
behavior seen for bacterial P450s,[16,30] only small shifts are typically 
seen for microsomal mammalian CYPs such as those of interest 
here,[26,31] whose distal pockets are larger and more flexible.[1,2] It is 
noted, on the other hand, that BHT binding to both enzymes studied 
here does activate out-of-plane (oop) modes at 318 and ~500 cm−1. 
The key ν(Fe-S) mode is enhanced only via excitation within the 
Fe-S charge transfer transition that occurs near 360 nm for the 
(substrate-bound) ferric HS state.[24] Thus, in Figure 2 this mode is 
observed as a relatively strong feature appearing at 353 cm−1 in the 
BHT-bound WT enzyme and at 347 cm−1 for the BHT-bound CYP2B4 
F429H. While the 347 cm−1 feature observed in the spectrum of the 
F429H mutant is accidently degenerate with the 347 cm−1 feature seen 
in with Soret excitation (Figure 1, Trace D left), the two features 
correspond to two different modes; i.e., the ν(Fe-S) and the ν8 modes, 
respectively. Convincing evidence for this is presented in the 
Supporting Information, where it is shown that the observed 
bandwidths are substantially broader for these 353/347 cm−1 features 
than those observed for the heme modes (Figure S2). 
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Figure 2 The low frequency rR spectra of ferric CYP2B4, wild-type BHT-bound (A) 
and F429H mutant BHT-bound (B). Spectra measured with 356 nm excitation line and 
normalized to the ν7 mode at 676 cm−1. 
The observed 6 cm−1 shift of ν(Fe-S) to lower frequency for 
F429H is qualitatively consistent with expectations based on the 
reduction of effective negative charge on the thiolate, in agreement 
with recent computations.[14,15] Similar earlier rR work with CYP101[17] 
and CYP102,[16] led to unexpected results; i.e., removal of existing H-
bond donors led either to no effect on the observed ν(Fe-S) frequency 
or an unexpected decrease,[17] while an attempt to introduce a new H-
bond donor residue to the proximal pocket of CYP102 (i.e., F393H) 
failed to induce any observable shift of its ν(Fe-S) mode.[16] The 
former result was later suggested to be attributable to vibrational 
mode reorganization.[14] The absence of any changes on the ν(Fe-S) 
mode for the F393H mutant of CYP102 was interpreted as evidence 
that the histidyl residue was not in a proper orientation to H-bond to 
the proximal cysteine thiolate fragment.[16,32] Given these 
complications encountered in these previous rR studies, it is satisfying 
that the present results agree with the predicted influence on the Fe-S 
bond strength.[14,15] 
The new H-bonding modulation of the Fe-S bond strength is also 
reflected in the altered electronic structure of the trans-axial Fe-C-O 
linkage of the ferrous CO adduct. Thus, as shown in Figure 3 (top), the 
ν(Fe-C) shifts up by 3 cm−1 for the mutant (i.e., 463 → 466 and 473 
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→476 cm−1 for the SF and BHT-bound comparisons), with the ν(C-O) 
modes also shifting up by 5–7cm−1 for the same comparisons (i.e., 
1957 →1962 and 1945→1952 cm−1). These directly correlated shifts of 
the ν(Fe-C) and ν(C-O) modes, both to higher frequency, are 
indicative of a diminished σ-donation of the trans-axial proximal 
thiolate ligand resulting from the newly introduced H-bonding histidine 
residue, such behavior being in agreement with predictions made from 
several high-level computational studies.[14,15,33] It is noted that earlier 
computational work, supported with modest experimental data for 
models, has previously been used to argue this point for the 
isoelectronic ferric NO adducts.[34] 
 
Figure 3 The low (left) and high (right) frequency rR spectra of ferrous CO adducts 
of CYP2B4, wild-type substrate-free (A), wild-type BHT-bound (B), F429H mutant 
substrate-free (C) and F429H mutant BHT-bound (D). Spectra measured with 442 nm 
excitation line and normalized to the ν7 and ν4 modes for low and high frequency 
region, respectively. The bottom graph shows linear correlation between ν(Fe-C) and 
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ν(C-O) frequencies, the open squares represent wild type truncated CYP2B4,[40] the 
solid squares indicate points for F429H mutants and the stars show mammalian 
NOSs.[37–39] 
Furthermore, the behavior seen here for the vibrational modes 
of the Fe-C-O fragment is satisfyingly consistent with data reported for 
CO adducts of NOS.[23] Thus, the plots shown at the bottom of Figure 3 
present data acquired for CO adducts of mammalian NOS (stars), the 
CO adducts of WT CYP2B4 under various conditions (open squares) 
and the two points obtained here for the F429H mutant of CYP2B4 
(solid squares); additional data reported for bacterial NOS proteins, as 
well as the isoelectronic Fe(III)NO adducts of cytochromes P450 and 
model compounds, are given in Figure S3 of Supporting Information. 
The inverse correlations of the ν(Fe-C) and ν(C-O) modes are 
generally accepted to reliably reflect variations in polarity of the distal 
heme pocket,[33,35] with displacements from one another along the 
vertical direction being the result of differences in the strength of the 
proximal ligand. Thus, the displacement of the NOS line from the 
CYP2B4 line arises because the Fe-S bonds of the NOSs are weakened 
by the presence of an H-bond from a conserved tryptophan residue in 
the proximal pocket; i.e., their ν(Fe-S) stretching frequencies 
generally occur near 338 cm−1,[36] approximately 12–14 cm−1 lower 
than for cytochromes P450. As can be seen in Figure 3, the points 
derived for the F429H mutant of CYP2B4 indeed are shifted towards 
the line for the NOS proteins, a shift entirely consistent with the 
observed 6 cm−1 lowering of the ν(Fe-S) for this mutant.[37–39] 
Finally, it is noteworthy that the remarkable structural 
sensitivity of the rR technique reveals small, but clearly detectable, 
mutation-induced changes for particular heme modes of the F429H 
mutant. A complex difference pattern (Figure 4, trace C) is obtained 
when comparing the rR spectra for the SF forms of ferrous CO adducts 
of the WT and F429H mutant. A similar difference plot obtained for the 
pair of BHT-bound forms is given in trace D. These data show that, 
while the mutation does not significantly change the basic heme 
structure, as reflected in the constancy of the core-sensitive ν3 and ν11 
modes, changes are evident in the spectral region associated with the 
ν(C=C) modes of the peripheral vinyl groups. The most reasonable 
interpretation of these difference patterns is that the vinyl mode 
envelope is shifted to slightly higher frequency, behavior which is 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Angewandte Chemie International Edition, Vol. 51, No. 41 (October 2012): pg. 10403-10407. DOI. This article is © Wiley-
VCH Verlag and permission has been granted for this version to appear in e-Publications@Marquette. Wiley-VCH Verlag 
does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express 
permission from Wiley-VCH Verlag. 
8 
 
consistent with out-of-plane displacement of the vinyl groups.[16] This 
displacement diminishes the conjugation of the vinyl groups with the 
heme macrocyle π-system, with the result that the ν2 core mode, 
associated with stretching of the Cβ-Cβ bonds of the pyrrole ring to 
which the vinyls are attached,[28] is also altered, experiencing an 
increased resonance enhancement. Significantly, all of these changes 
are observed for modes of molecular fragments localized at or near the 
2- and/or 4-vinyl groups and are therefore entirely consistent with the 
proposed interaction of the newly introduced histidyl imidazole with 
the pyrrole A-ring, based on inspection of recently the acquired x-ray 
crystal structure of the mutant.[LAW, unpublished] 
 
Figure 4 The high frequency rR spectra of ferrous CO adducts of substrate-free 
wild-type CYP2B4 (A) and F429H mutant (B). Spectra were normalized to the glycerol 
mode at 1468 cm−1. The traces (C) and (D) are difference traces of ferrous CO 
adducts of CYP2B4 wild-type and 429H mutant in substrate-free form (C) and in BHT-
bound state (D). 
In summary, the present results show that the newly introduced 
H-bond does indeed lead to a shift of the ν(Fe-S) stretching mode to 
lower frequency, documenting a weakening of this bond, as predicted 
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by theory.[14,15] Furthermore, the impact of this modulation of Fe-S 
bond strength is transmitted to the heme iron linkage with a trans-
axial diatomic ligand (CO), as reflected in the observed behavior of the 
ν(Fe-C) and ν(C-O ) modes of the Fe-C-O fragment,[23,41] such 
electronic effects holding potential implications for functional 
properties. Finally, changes in certain heme vibrational modes provide 
convincing evidence for the presence of an intimate interaction 
between the replacement residue, 429H, and the heme pyrrole A ring, 
a structural feature that is suggested from inspection of preliminary X-
ray crystallographic data.[LAW, unpublished] 
Experimental Section 
Plasmid for the truncated mutant was constructed from pLW01-
wild type full length P4502B4 plasmid.[42] The cDNA coding for the 19 
amino acids at the N-terminus (amino acids 3-21 of WT CYP2B4) were 
removed using NcoI restriction sites which had been inserted at 
position 3 and 21 by site directed mutagenesis. After removing the 
cDNA between the two NcoI sites, the remainder of the plasmid was 
religated by T4 DNA ligase (Invitrogen, NY). The following mutations, 
E2A, G22K, H23K, P24T, K25S, A26S, H27K, R29K, H226Y and F429H 
were then introduced into the Δ3–21 WT CYP2B4, using a QuikChange 
Site-Directed Mutagenesis Kit (Stratagene) to generate the F429H 
mutant of the truncated form of CYP2B4. The truncated form of 
CYP2B4 (all of the mutations indicated above, minus the F429H 
mutation), considered WT” above, is the form which had been 
previously engineered to allow successful crystallization when bound to 
different compounds.[43] 
The plasmid pLW01 CYP450 2B4 F429H with cDNA for the 
mutant or WT CYP2B4 was transformed into C41 (DE3) cells. The cells 
were grown in TB medium at 23°C and induced with IPTG, 
supplemented with delta-aminolevulinic acid at induction and ethanol 
thirty minutes after induction. The induced cell culture was harvested 
~120 hr after induction. 
The protein samples were isolated and purified as previously 
described.[44] Butylated hydroxytoluene (BHT) was added to all buffers 
to prevent conversion to cytochrome P420 during purification. The 
protein was eluted from hydroxyapatite column using buffer containing 
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0.4 M K2HPO4/KH2PO4 pH 7.4 and 20% glycerol. The purified protein 
was diluted into a final buffer containing 20% glycerol and 0.1 M 
K2HPO4/KH2PO4 pH 7.4 and concentrated to ~1 mM using 50,000 
MWCO VivaSpin 20. 
The rR measurements 
All samples are ~ 0.4mM in heme. All further details, including 
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